Key details
Sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Enrollment target
~80 participants
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
21 Years – 110 Years
Last updated February 2026